---
document_datetime: 2025-11-24 14:24:02
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/lupkynis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: lupkynis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.3849531
conversion_datetime: 2025-12-24 22:52:02.823923
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Lupkynis

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number        | Scope                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|---------------------------|-----------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| PSUR /EMA/PSUR/0000268975 | In view of available data on fatigue from clinical trials, spontaneous reports including in 237 cases with a close temporal | 18/09/2025                          | 17/11/2025                                  | SmPC and PL                      | Variation |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                          | relationship, 10 cases with positive de- challenge, the PRAC considers a causal relationship between voclosporin and fatigue is at least a reasonable possibility. The PRAC concluded that the product information of products containing voclosporin should be amended accordingly.                                                                                                                                                                 |            |            |                        |
|------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| Variation type IA_IN / EMA/VR/0000294585 | B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.b Primary packaging site - Accepted                                                                                                                                                                                                                                                                         | 10/09/2025 | N/A        |                        |
| Variation type IB / EMA/VR/0000275046    | This was an application for a group of variations. B.II.f.1.b Extension of the shelf life of the finished product - B.II.f.1.b.1 As packaged for sale (supported by real time data) - Accepted B.II.f.1 Change in the shelf-life or storage conditions of the finished product - B.II.f.1.e Change to an approved stability protocol - Accepted B.II.e.1 Change in immediate packaging of the finished product - B.II.e.1.z Other changes - Accepted | 18/06/2025 | 17/11/2025 | SmPC, Labelling and PL |